Wuhan Hiteck Biological Pharma Co.,Ltd

¥22.58As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300683Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (11.08%)
Div yield —
ROE (9.12%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.16)
PE TTM —
TSR TTM (34.47%)
Mkt cap ¥2.956B
ROIC (14.15%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥24
4.25%
(18.85%)
Buy 11|1|2|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.29
0.29
0.31
0.30
13.19%
4.93%
1.04%
0.02%
Revenue¥M
313.3
329.3
322.8
316.3
(1.10%)
5.02%
5.84%
4.92%
Peers (US$443.1M)
Cap (US$)
PE
448.7M
16.25x
436.6M
—
444.5M
17.80x
Capital
TTM
5Y
10Y
Leveragex
3.296
0.107
0.096
EBIT/Intx
0.324
0.187
0.189
Own earn%
36.30
36.24
31.52
Sh yield%
34.87
43.98
43.54
Owners
Insiders/Inst%
7.49
70.09
Short interest%
2.19
SBC / revenue%
1.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
8–14
$1 testx
0.1
Incr. ROIC%
8